c

Nice | Rivaroxaban for treating PE and preventing recurrent embolism

2nd August 2013 by Louise Hudman

Another guideline about Rivaroxaban. Guidance was published in 2012 advising that Rivaroxaban could be used in the treatment of DVT. At that point, there was no guidance about its use in PEs. Since then a study has shown that it is as effective as Warfarin in the treatment of PE. Therefore this new guideline advises that Rivaroxaban can be used in the treatment of PE and for the prevention of recurrent PE and DVT.

Its main advantage is that it does not need monitoring. Its main disadvantage is that its effects are not easily reversible. It is also expensive.

 

Read more

No credit card details needed – it takes two minutes.

Join free trial

Login

Already a member? Login to view this content.

Login

"I’ve done respiratory nursing clinics through Frimley ICS Primary Care Staff Bank and it was such a great experience. During my clinic I realised how valued and needed my skills are. Locuming gave me a great sense of pride and enthusiasm and I felt respected for my work. It was really easy to book and get paid too. I would recommend LocumDeck for Nurses to my colleagues."

Katrina Munro, Nurse Ambassador, Frimley Training Hub

See the full list of features within our NASGP membership plans

Membership